[1] Asselta R, Duga S, Tenchini ML.The molecular basis of quantitative fibrinogen disorders[J]. J Thromb Haemost,2006,4(10):2115-2129.
[2] Mensahand PK, Gooding R.Surgery in patients with inherited bleeding disorders[J]. Anaesthesia,2015,70(Suppl 1):112-120.
[3] Wagstaff W.Clinical practice of transfusion medicine[J]. J Clin Pathol,1997,72(3):288-289.
[4] 杨纪春, 马端. 凝血因子Ⅶ和Ⅺ异常的研究进展[J]. 中国产前诊断杂志(电子版),2016,8(2):39-43.
[5] Benlakhal F, Mura T, Schved JF, et al.A retrospective analysis of 157 surgical procedures performed without replacement therapy in 83 unrelated factor Ⅶ-deficient patients[J]. J Thromb Haemost,2011,9(6):1149-1156.
[6] Bornikova L, Peyvandi F, Allen G, et al.Fibrinogen replacement therapy for congenital fibrinogen deficiency[J].J Thromb Haemost,2011,9(9):1687-1704.
[7] Escobar MA, Maahs J, Hellman E, et al.Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres[J]. Haemophilia,2012,18(6):971-981.
